Skip to main content

Table 2 Distribution of studied patients according to their disease duration, current medication, and treatment duration (No. = 73)

From: Medication adherence to disease-modifying anti-rheumatic drugs among patients with rheumatoid arthritis at Assiut University Hospital, Egypt

Items

No.

Percent

Disease duration (years)

 < 10

30

41.1

 10–20

28

38.4

 > 20

15

20.5

 Mean ± SD

11.79 ± 7.84

 Median (range)

10.0 (1.0–35.0)

Current medications*

 Hydroxychloroquine

60

82.19

 Methotrexate

27

36.98

 Leflunomide

45

61.64

 Sulphasalazine

11

15.06

 Corticosteroid

15

20.54

Treatment duration (years)

 < 10

34

46.6

 10–20

25

34.2

 > 20

14

19.2

 Mean ± SD

11.06 ± 7.95

 Median (range)

10.0 (0.5–35.0)

  1. No. number, SD standard deviation
  2. *More than one medication was allowed